Vancomycin 5gm Inj, 1 Vial
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is typically administered as an infusion into a vein over a period of time. In some cases, it may be given orally or through a feeding tube instead of as an injection, if deemed necessary by your healthcare provider.
Storing and Disposing of Your Medication
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.
Missing a Dose
If you miss a dose, contact your doctor to receive guidance on what to do next.
Lifestyle & Tips
- Report any changes in hearing or ringing in the ears immediately.
- Report any signs of kidney problems, such as decreased urination or swelling.
- Inform healthcare providers if you experience flushing, rash, or itching during or after the infusion (Red Man Syndrome). This can often be managed by slowing down the infusion rate.
- Stay well-hydrated unless otherwise instructed by your doctor.
Available Forms & Alternatives
Available Strengths:
- Vancomycin 1000mg Inj
- Vancomycin 500mg Vial Forinjection
- Vancomycin 500mg Inj, 1 Vial
- Vancomycin 10gm Inj, 1 Vial
- Vancomycin 5gm Inj, 1 Vial
- Vancomycin 1000mg Inj (ad-Vantage)
- Vancomycin 5gm Inj, 1 Vial
- Vancomycin 750mg Inj, 1 Vial
- Vancomycin 1gm Inj, 1 Vial
- Vancomycin 125mg Capsules
- Vancomycin 250mg Capsules
- Vancomycin 1gm/200m Inj 12x200ml
- Vancomycin 250mg/5ml Oral Solution
- Vancomycin 10gm Inj, 1 Vial
- Vancomycin 1.25gm Inj 1 Vial
- Vancomycin 25mg/ml Oral Soln 300ml
- Vancomycin 25mg/ml Oral Soln 150ml
- Vancomycin 25mg/ml Oral Soln 300ml
- Vancomycin 25mg/ml Oral Soln 150ml
- Vancomycin 50mg/ml Oral Solution
- Vancomycin 1.5mg Inj, 1 Vial
- Vancomycin 1.75gm/350ml Inj, 350ml
- Vancomycin 750mg/150ml Inj, 150ml
- Vancomycin 1.5gm/300ml Inj, 300ml
- Vancomycin 500mg/100ml Inj, 100ml
- Vancomycin 125mg Capsules
- Vancomycin 250mg Capsules
- Vancomycin Hcl 1.75gm Inj, 1 Vial
- Vancomycin Hcl 2gm Sdv Inj, 1 Vial
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Severe skin reactions, such as:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions that can affect body organs and be life-threatening
+ Symptoms may include:
- Red, swollen, blistered, or peeling skin
- Red or irritated eyes
- Sores in the mouth, throat, nose, eyes, genitals, or skin
- Fever
- Chills
- Body aches
- Shortness of breath
- Swollen glands
If you receive this medication through injection (intravenous administration):
+ Fever
+ Chills
+ Sore throat
+ Pain when passing urine
+ Changes in balance
+ Flushing
+ Rash on the face, neck, trunk, and arms during infusion
If the medication is administered too quickly, you may experience:
+ Shortness of breath or wheezing
+ Itching
+ Muscle pain
+ Chest pain
+ Signs of low blood pressure, such as dizziness or fainting
If you notice any signs of tissue damage at the injection site, such as:
+ Redness
+ Burning
+ Pain
+ Swelling
+ Blisters
+ Skin sores
+ Leaking of fluid, inform your nurse immediately
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:
Diarrhea
Stomach pain
Upset stomach
Vomiting
This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe rash, hives, or itching
- Swelling of the face, lips, tongue, or throat
- Difficulty breathing or swallowing
- Dizziness or lightheadedness
- Ringing in the ears (tinnitus) or hearing loss
- Decreased urination or swelling in the legs/feet
- Fever, chills, or sore throat (signs of neutropenia)
- Pain, redness, or swelling at the injection site
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist assess potential interactions between this medication and other substances you are taking.
* Any existing health problems, as this medication may interact with certain conditions.
To ensure your safety, it is crucial to verify that this medication can be taken safely with all your current medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
Kidney problems, such as kidney failure, have been associated with this drug. If you have a history of kidney problems, notify your doctor promptly.
Regular blood work and other laboratory tests, as directed by your doctor, are crucial to monitor your health while taking this medication.
Long-term use of this drug may increase the risk of permanent hearing loss. Do not exceed the prescribed duration of treatment. Immediately report any changes in hearing or hearing loss to your doctor. Your doctor may recommend regular hearing tests during treatment.
Do not use this medication for an extended period, as this may lead to a secondary infection.
Antibiotics, including this drug, can cause diarrhea. Although rare, a severe form of diarrhea called C. diff-associated diarrhea (CDAD) may occur, potentially leading to life-threatening bowel problems. CDAD can develop during or several months after antibiotic treatment. If you experience stomach pain, cramps, or loose, watery, or bloody stools, contact your doctor immediately. Before treating diarrhea, consult with your doctor.
This medication is not approved for injection into the eye, as it has been associated with eye problems, including permanent vision loss, when administered via this route.
If you are 65 years or older, exercise caution when using this medication, as you may be more susceptible to side effects.
If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks of this medication with your doctor. For women of childbearing age, your doctor may require a pregnancy test before initiating treatment to confirm that you are not pregnant.
Overdose Information
Overdose Symptoms:
- Severe kidney damage (renal failure)
- Hearing loss or deafness
- Severe hypotension
- Red Man Syndrome (severe flushing, rash, pruritus, tachycardia, hypotension)
What to Do:
Discontinue vancomycin. Provide supportive care, maintain hydration, and monitor renal function. Hemodialysis is not effective for removing vancomycin. Contact a poison control center (e.g., 1-800-222-1222) or seek emergency medical attention immediately.
Drug Interactions
Major Interactions
- Aminoglycosides (e.g., gentamicin, tobramycin, amikacin): Increased risk of nephrotoxicity and ototoxicity.
- Loop diuretics (e.g., furosemide, bumetanide): Increased risk of ototoxicity.
- Cisplatin: Increased risk of nephrotoxicity and ototoxicity.
- Cyclosporine, Tacrolimus: Increased risk of nephrotoxicity.
Moderate Interactions
- Neuromuscular blocking agents (e.g., succinylcholine, rocuronium): Vancomycin may enhance or prolong the neuromuscular blockade.
- Anesthetic agents: May increase the risk of histamine release and 'red man syndrome' when co-administered or given immediately after vancomycin infusion.
- NSAIDs (e.g., ibuprofen, naproxen): May increase risk of nephrotoxicity, especially in patients with pre-existing renal impairment.
Monitoring
Baseline Monitoring
Rationale: Vancomycin is primarily renally eliminated; renal impairment necessitates dose adjustment and increases risk of toxicity.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline for potential ototoxicity.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline for potential neutropenia or thrombocytopenia.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Before the 4th or 5th dose (at steady state), then at least weekly, or more frequently with dose changes, renal function changes, or clinical instability.
Target: 10-15 mcg/mL for most infections; 15-20 mcg/mL for serious infections (e.g., endocarditis, osteomyelitis, meningitis, HAP/VAP, bacteremia, severe C. difficile).
Action Threshold: Levels outside target range require dose adjustment; levels >20 mcg/mL increase risk of toxicity.
Frequency: Daily or every 2-3 days initially, then at least 2-3 times per week, or more frequently if renal function is unstable or co-administered nephrotoxic drugs.
Target: Stable or within patient's baseline.
Action Threshold: Increase in SCr by ≥0.5 mg/dL or ≥50% from baseline (whichever is smaller) suggests acute kidney injury and requires dose adjustment or discontinuation.
Frequency: Daily
Target: Adequate urine output.
Action Threshold: Oliguria or anuria may indicate renal impairment.
Frequency: Weekly, or more frequently if signs of myelosuppression.
Target: WBC and platelet counts within normal limits.
Action Threshold: Neutropenia (ANC <1000 cells/mm³) or thrombocytopenia may require discontinuation.
Symptom Monitoring
- Red man syndrome (flushing, rash, pruritus, urticaria, tachycardia, hypotension) during or shortly after infusion
- Signs of nephrotoxicity (decreased urine output, edema, fatigue, nausea, confusion)
- Signs of ototoxicity (tinnitus, hearing loss, vertigo)
- Signs of hypersensitivity reactions (rash, fever, chills, difficulty breathing)
- Signs of neutropenia (fever, sore throat, signs of infection)
- Signs of phlebitis or irritation at injection site
Special Patient Groups
Pregnancy
Vancomycin crosses the placenta. Use during pregnancy only if clearly needed and the potential benefit outweighs the potential risk to the fetus. Monitor maternal vancomycin levels and fetal auditory function.
Trimester-Specific Risks:
Lactation
Vancomycin is excreted in breast milk in low concentrations. Generally considered compatible with breastfeeding, but monitor the infant for potential adverse effects.
Pediatric Use
Dosing is weight-based and requires careful therapeutic drug monitoring (TDM) due to variable pharmacokinetics and higher clearance rates compared to adults. Neonates and infants require specific dosing regimens based on gestational and postnatal age. Risk of nephrotoxicity and ototoxicity is present, requiring close monitoring.
Geriatric Use
Elderly patients often have reduced renal function, which significantly prolongs vancomycin half-life and increases the risk of accumulation and toxicity. Dose adjustments based on renal function and therapeutic drug monitoring are essential. Increased susceptibility to ototoxicity and nephrotoxicity.
Clinical Information
Clinical Pearls
- Therapeutic Drug Monitoring (TDM) is crucial for vancomycin to ensure efficacy and minimize toxicity. Target trough levels are typically 10-15 mcg/mL for most infections and 15-20 mcg/mL for serious infections (e.g., MRSA bacteremia, endocarditis, osteomyelitis, meningitis).
- Infuse vancomycin slowly over at least 60 minutes (for doses up to 1g) or 90-120 minutes (for doses >1g) to prevent 'Red Man Syndrome' (histamine-mediated reaction). Rapid infusion is a common cause of this reaction.
- Vancomycin is NOT absorbed orally for systemic infections; oral vancomycin is used ONLY for Clostridioides difficile infection (CDI).
- Monitor renal function closely, especially in patients receiving concomitant nephrotoxic agents or those with pre-existing renal impairment.
- While ototoxicity is a known adverse effect, it is rare with current dosing strategies and TDM, and often associated with very high peak levels or concomitant ototoxic drugs.
- Consider continuous infusion vancomycin in critically ill patients or those with fluctuating renal function to maintain more stable drug levels and potentially reduce nephrotoxicity.
Alternative Therapies
- Linezolid (for MRSA, VRE)
- Daptomycin (for MRSA, VRE)
- Ceftaroline (for MRSA)
- Telavancin (for MRSA)
- Oritavancin (for MRSA)
- Dalbavancin (for MRSA)
- Tigecycline (for MRSA, VRE)
- Quinupristin/Dalfopristin (for VRE, MRSA)
- Metronidazole (for C. difficile infection, oral)
- Fidaxomicin (for C. difficile infection, oral)